ISOMORPHIC LABS RAISES $2.1B FOR AI DRUG DISCOVERY

Alphabet's Isomorphic Labs, founded by DeepMind co-founder Demis Hassabis, closed a $2.1 billion Series B round led by Thrive Capital. The funding will accelerate development of its IsoDDE platform and push drug candidates toward clinical trials.